CUNY School of Medicine has been awarded two R25 grants from NIH to support Diversity in Neuroscience Research
Dr. Gonzalo Torres, Medical professor and Chair of the Department of Molecular Cellular & Biomedical Sciences at the CUNY School of Medicine, received two awards totaling $2.5 million. The National Institute of Neurological Disorders (NINDS) / NIH has awarded $ 1.25 million to Dr. Gonzalo Torres and the CUNY School of Medicine to establish the Mentoring Institute for Neuroscience Diversity Scholars (MINDS) through an R25 mechanism (2019-2024). The mission of the MINDS program is to promote the advancement of underrepresented junior faculty members interested in NINDS-related research at academic institutions in the US.
Dr. Gonzalo Torres and CUNY School of Medicine were also rewarded $1.25 Million from the National Institute of Drug Abuse (NIDA)/NIH to establish the center for Underrepresented Research in Addiction (CURA) through an R25 mechanism (2019 – 2024). CURA’s mission is to promote the advancement of underrepresented junior faculty members interested in drug addiction research at academic research institutions in the US.
“The CUNY School of Medicine is one of the most diverse medical schools in the country,” says Torres, “I wanted to come here to help grow the diversity of its researchers and faculty.” Torres continues, “This is an exciting time to be here at the CUNY School of Medicine. Being a new medical school, there exist many opportunities for collaborative research, teaching, and mentoring initiatives.” Both awards will support a number of activities including mentoring, networking, professional development, and attendance at scientific conferences.